A Trial of HRS-5965 Tablets in Primary IgA Nephropathy

NCT06137768 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

123

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary IgA Nephropathy

Interventions

DRUG: HRS-5965
DRUG: Placebo

Sponsor

Chengdu Suncadia Medicine Co., Ltd.